Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

ImmunityBio, Inc. Common Stock (IBRX)

Biological Products, (no Disgnostic Substances)

https://www.immunitybio.com

ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.

3530 JOHN HOPKINS COURT
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/10/2021

Market Cap

2,820,958,650

Shares Outstanding

667,710,000

Weighted SO

670,331,089

Total Employees

N/A

Upcoming Earnings

08/13/2024

Beta

-0.3110

Last Div

0.0000

Range

1.25-10.53

Chg

0.0700

Avg Vol

3368937

Mkt Cap

2820958650

Exch

NASDAQ

Country

US

Phone

858 633 0300

DCF Diff

5.2927

DCF

-1.2590

Div Yield

0.0000

P/S

2156.6962

EV Multiple

-10.5408

P/FV

-3.9836

Div Yield %

0.0000

P/E

-4.6551

PEG

-2.4659

Payout

0.0000

Current Ratio

3.9097

Quick Ratio

3.8805

Cash Ratio

2.0947

DSO

574.8471

DIO

36.5000

Op Cycle

611.3471

DPO

409.4812

CCC

201.8659

Gross Margin

-12.8456

Op Margin

-274.5933

Pretax Margin

-456.9801

Net Margin

-456.9167

Eff Tax Rate

0.0151

ROA

-1.3451

ROE

1.0006

ROCE

-0.9397

NI/EBT

0.9999

EBT/EBIT

1.6642

EBIT/Rev

-274.5933

Debt Ratio

2.1663

D/E

-1.3782

LT Debt/Cap

3.7083

Total Debt/Cap

3.6440

Int Coverage

-74.8579

CF/Debt

-0.4046

Equity Multi

-0.6362

Rec Turnover

0.6350

Pay Turnover

0.8914

Inv Turnover

10.0000

FA Turnover

0.0074

Asset Turnover

0.0029

OCF/Share

-0.5669

FCF/Share

-0.6010

Cash/Share

0.3173

OCF/Sales

-297.7309

FCF/OCF

1.0601

CF Coverage

-0.4046

ST Coverage

-62.1005

CapEx Coverage

-16.6303

Div&CapEx Cov

-16.6303

P/BV

-3.9836

P/B

-3.9836

P/S

2156.6962

P/E

-4.6551

P/FCF

-6.8329

P/OCF

-7.1440

P/CF

-7.1440

PEG

-2.4659

P/S

2156.6962

EV Multiple

-10.5408

P/FV

-3.9836

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation